查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466587

臨床前 CRO 市場：按服務、應用和最終用戶分類 - 2024-2030 年全球預測

Preclinical CRO Market by Services (Bioanalysis & DMPK Studies, Toxicology Testing), Application (Cardiovascular Disease, Dermatology, Gastrointestinal), End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年臨床前CRO市場規模為62.5億美元，預計2024年將達68.5億美元，2030年將達到119.5億美元，複合年成長率為9.68%。

臨床前 CRO 是支援中心，提供必要的研發活動 (R&D) 專業知識，透過動物試驗將候選藥物帶入臨床階段。臨床前測試服務包括多項研究，這些研究對於評估藥物在動物模型中的功效和安全性以及提交臨床實驗(IND) 申請非常重要。在臨床前試驗中，CRO受申辦者（例如生物製藥公司）聘請，代表申辦者執行一系列業務，同時承擔各種技術和行政職責。處於臨床前階段的藥物數量迅速增加，以及藥物開發的研發 (R&D) 預算不斷增加，正在推動臨床前 CRO 服務的使用。然而，臨床前CRO服務涉及高成本和耗時的流程，阻礙了市場成長。高通量篩檢和In Silico建模等技術進步預計將實現更有效率、更具成本效益的臨床前研究，為市場成長創造機會。

主要市場統計
基準年[2023] 62.5億美元
預測年份 [2024] 68.5億美元
預測年份 [2030] 119.5億美元
複合年成長率（%） 9.68%

毒理學測試服務的使用率迅速增加，重點關注服務安全和監管合規方面

生物分析和 DMPK 研究對於了解潛在療法的吸收、分佈、代謝和排泄 (ADME) 特性至關重要。該部分提供了有關生物系統中藥物行為的重要資訊，對於確定劑量和評估安全性至關重要。這些研究優先在藥物開發的早期階段進行，此時需要詳細了解藥物的藥物動力學特徵。製藥和生物技術公司通常依賴具有生物分析方法和最尖端科技專業知識的外部 CRO。毒理學測試服務對於評估候選藥物的安全性、確保其進一步開發和人類消費的安全性至關重要。該領域涉及各種測試來評估化合物對生物體的潛在不利影響。這些測試在進行臨床試驗之前非常重要，主要解決藥物必須通過才能獲得核准的監管要求。對於所有需要證明其產品無毒的製藥和生物技術公司來說，這一點至關重要。

最終用戶：生物製藥公司擴大臨床前 CRO 的使用

生物製藥公司是臨床前 CRO 的主要客戶，利用他們的服務來開發和測試生物製藥。這些公司尋求與 CRO 合作，利用他們在藥理學、毒理學和分子生物學方面的專業知識。向生物製藥公司提供的服務通常包括功效和安全性評估、吸收、分佈、代謝和排泄 (ADME) 測試以及監管支持。與臨床前 CRO 合作使生物製藥公司能夠加快藥物開發流程、有效管理成本並有效滿足複雜的監管要求。政府機構和學術機構與臨床前 CRO 合作，進行公共衛生目的的研究和發展。這些合作關係支持新藥發現、疫苗開發和創新治療方法等計劃。臨床前 CRO 為這些機構提供了獲得其內部所沒有的專業資源和專業知識的機會。此外，CRO 還幫助進行高品質、合規的研究，從而實現突破性的醫學進步。政府/學術機構和 CRO 之間的合作對於彌合基礎研究和臨床應用之間的差距至關重要。醫療設備製造商依靠臨床前 CRO 的服務來檢驗其產品的安全性和有效性，然後再進行臨床試驗。這些公司受益於 CRO 的技術和監管專業知識來進行全面的生物醫學測試、動態評估和風險評估。為醫療設備公司量身定做的服務通常包括臨床前研究設計、原型測試以及對遵守國際標準和法規的支援。透過與 CRO 合作，醫療設備公司可以確保其產品符合最高品質和安全標準，確保順利過渡到臨床階段。

區域洞察

人口老化導致的非傳染性疾病以及污染和蟲害等環境條件變化引起的傳染性疾病空前增加，催生了醫療保健領域對有效藥物開發的需求，從而導致對臨床前 CRO 服務的需求日益迫切。 、中東和非洲地區不斷增加。亞太地區政府為促進醫療設備和藥物開發領域的研發 (R&D) 活動而進行的投資預計將為臨床前 CRO 市場的參與者提供成長機會。 2021年8月，澳洲政府投資7,900萬美元用於醫療創新和研究計劃。歐盟新興經濟體建立了政府支持體系，透過優先考慮新技術和藥物開發的研究和創新來支持技術進步。各國政府推出了多項嚴格的法規和標準，以確保開發的藥品和設備安全、可靠和高品質。 2022年1月，決定在歐盟啟動修訂臨床試驗流程的臨床試驗法規（Regulation (EU) No 536/2014）。政府引入了臨床試驗資訊系統（CTIS）來協調監督和評估流程。因此，政府對醫療設備和藥物開發臨床試驗的持續支持預計將推動歐洲、中東和非洲臨床前 CRO 市場的成長。

FPNV定位矩陣

FPNV定位矩陣對於評估臨床前CRO市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對臨床前 CRO 市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告對以下幾個方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1. 臨床前CRO市場的市場規模與預測是多少？

2.臨床前CRO市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些？

3. 臨床前CRO市場的技術趨勢和法規結構是什麼？

4.臨床前CRO市場主要廠商的市場佔有率如何？

5. 進入臨床前CRO市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 製藥和生物製藥公司增加研發活動以開發新藥和治療方法
      • 製藥公司將藥物開發業務外包給 CRO 的趨勢增加
      • 個人化醫療的發展日益受到關注
    • 抑制因素
      • 與臨床前 CRO 服務相關的高成本和耗時的限制
    • 機會
      • 技術進步使臨床前研究更有效率、更具成本效益
      • 單株抗體、疫苗和細胞療法等生技藥品臨床前研究的巨大潛力
    • 任務
      • 國際監管機構制定的嚴格法規和準則
  • 市場區隔分析
    • 服務：毒理學測試服務的使用正在迅速增加，重點關注安全和監管合方面。
    • 最終用戶：改變生物製藥公司使用臨床前 CRO 的方式
  • 市場趨勢分析
    • 美洲的老牌製藥和生物製藥公司越來越多，先進的臨床前 CRO 平台也不斷引進。
    • 政府加強支持力度，擴大亞太地區新藥和醫療設備開發的研發活動
    • 政府對藥物開發活動的潛在資助將擴大歐洲、中東和非洲地區的臨床前 CRO 業務。
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析
  • 客戶客製化

第6章臨床前CRO市場：依服務分類

  • 生物分析和 DMPK 研究
  • 毒性試驗

第7章 臨床前 CRO 市場：依應用分類

  • 循環系統疾病
  • 皮膚科
  • 胃
  • 泌尿系統和女性健康
  • 血液學
  • 免疫疾病
  • 感染疾病
  • 代謝紊亂
  • 神經病學
  • 腫瘤學
  • 眼科
  • 呼吸系統疾病

第8章臨床前 CRO 市場：依最終使用者分類

  • 生物製藥公司
  • 政府和學術機構
  • 醫療設備公司

第9章美洲臨床前CRO市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區臨床前CRO市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲臨床前CRO市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
    • CRO公司TriApex完成君聯資本主導的C輪資金籌措
    • PsychoGenics 推出 eCube，一個用於新藥發現的人工智慧平台
    • 普魯士宣布大幅擴展臨床前研究和開發，以加速藥物安全決策
    • AmplifyBio 擴展了細胞療法的表徵並縮小了臨床前開發的差距
    • Clinchoice 透過收購 CRO 繼續擴張
    • QPS 在台灣開設新的臨床前研究設施
    • CRO Avanir 收購明訊
    • Apax 收購 Porsolt 多數股權，支持公司的成長策略並成為臨床前服務的全球領導者
    • Cryoport 宣布與 Syneos Health 建立策略合作夥伴關係，以推進細胞和基因治療
    • Crown Biosciences 與 ERS ​​Genomics 宣布簽署全球 CRISPR/Cas9 基因組編輯專利授權協議
    • Domain Therapeutics 與 Exprycyte 簽署免疫腫瘤學領域合作協議
    • 賽揚擴大早期臨床藥理學部門
    • ClinChoice 在 E 輪融資中籌集 1.5 億美元
    • Hella Biolab 宣布與 Charles River 簽署全球獨家授權合約
    • IonsGate 臨床前服務和 InSilicoTrials 合作

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-A339DAEFA51A

[195 Pages Report] The Preclinical CRO Market size was estimated at USD 6.25 billion in 2023 and expected to reach USD 6.85 billion in 2024, at a CAGR 9.68% to reach USD 11.95 billion by 2030.

A preclinical CRO is a support center providing expertise in research and development activities (R&D) essential for navigating a drug candidate through animal testing and forwarding it into the clinical phase. Preclinical research services encompass several studies critical to assessing drug efficacy & safety in animal models and complete Investigational New Drug (IND) filing studies. In a preclinical trial, CROs are hired by sponsors such as biopharma companies to perform a set of tasks, taking various technical and administrative responsibilities on the sponsor's behalf. A surge in the number of drugs in the preclinical phase and an increased research & development (R&D) budget for drug development are driving the usage of preclinical CRO services. The high cost and time-consuming process of preclinical CROS services hamper the market growth. Advances in technology, which include high-throughput screening and in silico modeling, enable more efficient and cost-effective preclinical research and are expected to create opportunities for market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 6.25 billion
Estimated Year [2024] USD 6.85 billion
Forecast Year [2030] USD 11.95 billion
CAGR (%) 9.68%

Services: Burgeoning usage of Toxicology testing services focusing on the safety and regulatory compliance aspects

Bioanalysis and DMPK studies are crucial for understanding potential therapeutic agents' absorption, distribution, metabolism, and excretion (ADME) properties. This segment provides vital information on the drug's behavior in a biological system, which is paramount for dosage determination and safety assessment. These studies are preferred in the early stages of drug development when detailed insight into the drug's pharmacokinetic profile is required. Pharmaceutical companies and biotechnology firms often rely on external CROs with specialized expertise in bioanalytical methodologies and state-of-the-art technologies. Toxicology testing services are vital for evaluating the safety profile of drug candidates, ensuring they are safe for further development and human consumption. This segment encompasses a range of studies to assess the potential adverse effects of compounds on living organisms. These tests are critical before advancing to clinical trials, catering mainly to regulatory requirements that drugs must pass for approval. They are indispensable for all pharmaceutical and biotechnological companies needing to demonstrate the non-toxic nature of their products.

End-User: Evolving usage of preclinical CRO by biopharmaceutical companies

Biopharmaceutical companies are primary clients of preclinical CROs, leveraging their services for the development and testing of biologic drugs. These companies seek CRO partnerships to access specialized expertise in pharmacology, toxicology, and molecular biology. Services offered to biopharmaceutical companies often include drug efficacy and safety assessments, absorption, distribution, metabolism, excretion (ADME) studies, and regulatory support. Collaborating with preclinical CROs enables biopharmaceutical companies to accelerate their drug development process, manage costs effectively, and navigate complex regulatory requirements efficiently. Government and academic institutes often engage with preclinical CROs for research and development initiatives fundamental to public health objectives. These partnerships support projects, including new drug discoveries, vaccine development, and innovative medical treatments. Preclinical CROs provide these institutions with access to specialized resources and expertise that may not be available in-house. Additionally, CROs assist in conducting high-quality, regulatory-compliant research studies that can lead to groundbreaking medical advancements. Collaborations between government / academic institutes and CROs are pivotal in bridging the gap between basic research and clinical application. Medical device companies utilize preclinical CRO services to validate the security and efficacy of their products before proceeding to clinical trials. These companies benefit from CROs' technical and regulatory expertise to conduct comprehensive biomedical testing, biomechanical evaluation, and risk assessment. Services tailored to medical device companies often encompass preclinical study design, prototype testing, and support in complying with international standards and regulations. By partnering with CROs, medical device companies can assure their products meet the highest quality and safety standards, facilitating smoother transitions into clinical phases.

Regional Insights

The unprecedented rise in non-communicable diseases among the geriatric population and communicable diseases caused by changing environmental conditions, such as pollution, and insect infestation, create a demand for effective drug development in the healthcare sector, subsequently increasing the need for preclinical CRO services across the Americas, Asia-Pacific, and EMEA. The investments made by the governments of Asia-Pacific to push research and development (R&D) activities of medical devices and drug development are estimated to provide growth opportunities for the preclinical CRO market players. In August 2021, the Australian government invested USD 79 million in medical innovation and research projects. The developed economies in the European Union have established a supportive government framework to boost technological advancements by prioritizing research and innovation of new technologies and drug development. The government introduces several stringent regulations and standards to ensure that the medicines and devices developed are safe, reliable, and of high quality. In January 2022, the Clinical Trials Regulation (Regulation (EU) No 536/2014) was set to launch in the EU to modify the clinical trial processes. The government introduced a Clinical Trials Information System (CTIS) to harmonize the supervision and assessment processes. Thus, the ongoing government support for clinical trials for medical devices and drug development is expected to fuel the growth of the preclinical CRO market in EMEA.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Preclinical CRO Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Preclinical CRO Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Preclinical CRO Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., AmplifyBio, Atuka Inc., BenchSci, Bioserve Biotechnologies (India) PVT Ltd. by REPROCELL Inc., Biotrofix, Inc., Celerion, Charles River Laboratories International, Inc., Crown Bioscience, Inc., CTI Clinical Trial and Consulting, Inc., Diag2Tec SAS, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Gubra, Hera Biolabs, ICON PLC, Immusmol SAS, ImQuest BioSciences, Inotiv, Inc., Intertek Group PLC, Invivotek by Genesis Biotechnology Group, LLC, IQVIA Inc., Jubilant Biosys Ltd. byJubilant Pharmova Limited Company, Laboratory Corporation of America Holding, MCI Group Holding SA, MD Biosciences, Medpace Holdings, Inc., Novartis AG, Parexel International Corporation., PharmaCircle LLC, Phenos GmbH, PPD by Thermo Fisher Scientific Inc., PsychoGenics Inc., QPS Holdings, LLC, Sanofi S.A., SCiAN Services Inc., SGS SA, Shanghai Medicilon Inc., Syneos Health, Inc., Transpharmation, Veristat, LLC, Vimta Labs Limited, and WuXi AppTec Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Preclinical CRO Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Services
    • Bioanalysis & DMPK Studies
    • Toxicology Testing
  • Application
    • Cardiovascular Disease
    • Dermatology
    • Gastrointestinal
    • Genitourinary & Women's Health
    • Hematology
    • Immunological Disorders
    • Infectious Diseases
    • Metabolic Disorders
    • Neurology
    • Oncology
    • Ophthalmology
    • Respiratory Disorders
  • End-User
    • Biopharmaceutical Companies
    • Government & Academic Institutes
    • Medical Device Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Preclinical CRO Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Preclinical CRO Market?

3. What are the technology trends and regulatory frameworks in the Preclinical CRO Market?

4. What is the market share of the leading vendors in the Preclinical CRO Market?

5. Which modes and strategic moves are suitable for entering the Preclinical CRO Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing R&D activities by pharmaceutical and biopharmaceutical companies to develop new drugs & therapies
      • 5.1.1.2. Rising trend of outsourcing drug development activities to CROs by pharmaceutical companies
      • 5.1.1.3. Growing focus on the development of personalized medicines
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and time-consuming constraints associated with preclinical CRO services
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing advances in technologies to enable more efficient and cost-effective preclinical research
      • 5.1.3.2. High potential for preclinical research for biologics, including monoclonal antibodies, vaccines, and cell therapies
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations and guidelines set by international regulatory authorities
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Services: Burgeoning usage of Toxicology testing services focusing on the safety and regulatory compliance aspects
    • 5.2.2. End-User: Evolving usage of preclinical CRO by biopharmaceutical companies
  • 5.3. Market Trend Analysis
    • 5.3.1. Presence of well-established pharmaceutical & biopharmaceutical companies and the rising introduction of advanced preclinical CRO platforms in the Americas
    • 5.3.2. Rising government support for expanding research & development activities into developing new drugs and medical devices in the Asia-Pacific region
    • 5.3.3. Potential government funding in drug development activities expands the preclinical CRO business in the EMEA region.
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis
  • 5.8. Client Customization

6. Preclinical CRO Market, by Services

  • 6.1. Introduction
  • 6.2. Bioanalysis & DMPK Studies
  • 6.3. Toxicology Testing

7. Preclinical CRO Market, by Application

  • 7.1. Introduction
  • 7.2. Cardiovascular Disease
  • 7.3. Dermatology
  • 7.4. Gastrointestinal
  • 7.5. Genitourinary & Women's Health
  • 7.6. Hematology
  • 7.7. Immunological Disorders
  • 7.8. Infectious Diseases
  • 7.9. Metabolic Disorders
  • 7.10. Neurology
  • 7.11. Oncology
  • 7.12. Ophthalmology
  • 7.13. Respiratory Disorders

8. Preclinical CRO Market, by End-User

  • 8.1. Introduction
  • 8.2. Biopharmaceutical Companies
  • 8.3. Government & Academic Institutes
  • 8.4. Medical Device Companies

9. Americas Preclinical CRO Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Preclinical CRO Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Preclinical CRO Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. CRO Company TriApex Completes Series C Financing Round Led by Legend Capital
    • 12.3.2. PsychoGenics Launches eCube, a New AI-Enabled Platform for Drug Discovery
    • 12.3.3. Proscia Announces Major Expansion in Preclinical R&D to Drive Faster Drug Safety Decisions
    • 12.3.4. AmplifyBio Expands Cell Therapy Characterization, Fills Gap in Preclinical Development
    • 12.3.5. Clinchoice Continues Expansion with CRO Acquisition
    • 12.3.6. QPS opens an additional preclinical research facility in Taiwan
    • 12.3.7. CRO Avania Acquires MAXIS
    • 12.3.8. Apax Acquires a Majority Stake in Porsolt to Support its Growth Strategy and Become a Global Leader in Preclinical Services
    • 12.3.9. Cryoport Announces Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies
    • 12.3.10. Crown Bioscience and ERS Genomics Announce Global CRISPR/Cas9 Licensing Agreement for Genome Editing Patents
    • 12.3.11. Domain Therapeutics and Explicyte Enter Partnership Agreement in Immuno-Oncology
    • 12.3.12. Celerion Expands Early Phase Clinical Pharmacology Units
    • 12.3.13. ClinChoice Raises USD 150 Million in Series E Round
    • 12.3.14. Hera BioLabs Announces Exclusive Global License With Charles River
    • 12.3.15. IonsGate Preclinical Services and InSilicoTrials Form Partnership

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. PRECLINICAL CRO MARKET RESEARCH PROCESS
  • FIGURE 2. PRECLINICAL CRO MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PRECLINICAL CRO MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PRECLINICAL CRO MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL PRECLINICAL CRO MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. PRECLINICAL CRO MARKET DYNAMICS
  • FIGURE 7. GLOBAL PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL PRECLINICAL CRO MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL PRECLINICAL CRO MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. PRECLINICAL CRO MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. PRECLINICAL CRO MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PRECLINICAL CRO MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PRECLINICAL CRO MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL PRECLINICAL CRO MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL PRECLINICAL CRO MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL PRECLINICAL CRO MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL PRECLINICAL CRO MARKET SIZE, BY BIOANALYSIS & DMPK STUDIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL PRECLINICAL CRO MARKET SIZE, BY BIOANALYSIS & DMPK STUDIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL PRECLINICAL CRO MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL PRECLINICAL CRO MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL PRECLINICAL CRO MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL PRECLINICAL CRO MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL PRECLINICAL CRO MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL PRECLINICAL CRO MARKET SIZE, BY DERMATOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL PRECLINICAL CRO MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL PRECLINICAL CRO MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL PRECLINICAL CRO MARKET SIZE, BY GENITOURINARY & WOMEN'S HEALTH, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL PRECLINICAL CRO MARKET SIZE, BY GENITOURINARY & WOMEN'S HEALTH, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL PRECLINICAL CRO MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL PRECLINICAL CRO MARKET SIZE, BY HEMATOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL PRECLINICAL CRO MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL PRECLINICAL CRO MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL PRECLINICAL CRO MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL PRECLINICAL CRO MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL PRECLINICAL CRO MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL PRECLINICAL CRO MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL PRECLINICAL CRO MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL PRECLINICAL CRO MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL PRECLINICAL CRO MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL PRECLINICAL CRO MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL PRECLINICAL CRO MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL PRECLINICAL CRO MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL PRECLINICAL CRO MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL PRECLINICAL CRO MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL PRECLINICAL CRO MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL PRECLINICAL CRO MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL PRECLINICAL CRO MARKET SIZE, BY GOVERNMENT & ACADEMIC INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL PRECLINICAL CRO MARKET SIZE, BY GOVERNMENT & ACADEMIC INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL PRECLINICAL CRO MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL PRECLINICAL CRO MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 55. ARGENTINA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 56. ARGENTINA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 57. ARGENTINA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 58. ARGENTINA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 61. BRAZIL PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 62. BRAZIL PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 63. BRAZIL PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 64. BRAZIL PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 65. BRAZIL PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 66. BRAZIL PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 67. CANADA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 68. CANADA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 69. CANADA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. CANADA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. CANADA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. CANADA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. MEXICO PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 74. MEXICO PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 75. MEXICO PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 76. MEXICO PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 77. MEXICO PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 78. MEXICO PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 79. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 80. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 81. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 84. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 85. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 86. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 96. AUSTRALIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 98. AUSTRALIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 100. AUSTRALIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 101. CHINA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 102. CHINA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 103. CHINA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 104. CHINA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 105. CHINA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 106. CHINA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 107. INDIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 108. INDIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 109. INDIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 110. INDIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 111. INDIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 112. INDIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 113. INDONESIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 114. INDONESIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 115. INDONESIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 116. INDONESIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 117. INDONESIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 118. INDONESIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 119. JAPAN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 120. JAPAN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 121. JAPAN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 122. JAPAN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 123. JAPAN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 124. JAPAN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 125. MALAYSIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 126. MALAYSIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 127. MALAYSIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 128. MALAYSIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 129. MALAYSIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 130. MALAYSIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 132. PHILIPPINES PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 134. PHILIPPINES PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 136. PHILIPPINES PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 137. SINGAPORE PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 138. SINGAPORE PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 139. SINGAPORE PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 140. SINGAPORE PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 141. SINGAPORE PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 142. SINGAPORE PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 144. SOUTH KOREA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. SOUTH KOREA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 148. SOUTH KOREA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 149. TAIWAN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 150. TAIWAN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 151. TAIWAN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 152. TAIWAN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 153. TAIWAN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 154. TAIWAN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 155. THAILAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 156. THAILAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 157. THAILAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 158. THAILAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 159. THAILAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 160. THAILAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 161. VIETNAM PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 162. VIETNAM PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 163. VIETNAM PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 164. VIETNAM PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 165. VIETNAM PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 166. VIETNAM PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 175. DENMARK PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 176. DENMARK PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 177. DENMARK PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 178. DENMARK PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 179. DENMARK PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 180. DENMARK PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 181. EGYPT PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 182. EGYPT PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 183. EGYPT PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 184. EGYPT PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 185. EGYPT PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. EGYPT PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. FINLAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 188. FINLAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 189. FINLAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 190. FINLAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 191. FINLAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 192. FINLAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 193. FRANCE PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 194. FRANCE PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 195. FRANCE PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. FRANCE PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. FRANCE PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 198. FRANCE PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 199. GERMANY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 200. GERMANY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 201. GERMANY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 202. GERMANY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 203. GERMANY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 204. GERMANY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 205. ISRAEL PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 206. ISRAEL PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 207. ISRAEL PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 208. ISRAEL PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 209. ISRAEL PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. ISRAEL PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. ITALY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 212. ITALY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 213. ITALY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 214. ITALY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 215. ITALY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 216. ITALY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 217. NETHERLANDS PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 218. NETHERLANDS PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 219. NETHERLANDS PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 220. NETHERLANDS PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 221. NETHERLANDS PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 222. NETHERLANDS PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 223. NIGERIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 224. NIGERIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 225. NIGERIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 226. NIGERIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 227. NIGERIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 228. NIGERIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 229. NORWAY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 230. NORWAY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 231. NORWAY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 232. NORWAY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 233. NORWAY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 234. NORWAY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 235. POLAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 236. POLAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 237. POLAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 238. POLAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 239. POLAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 240. POLAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 241. QATAR PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 242. QATAR PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 243. QATAR PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 244. QATAR PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 245. QATAR PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 246. QATAR PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 247. RUSSIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 248. RUSSIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 249. RUSSIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 250. RUSSIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 251. RUSSIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 252. RUSSIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 253. SAUDI ARABIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 254. SAUDI ARABIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 255. SAUDI ARABIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 256. SAUDI ARABIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 257. SAUDI ARABIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 258. SAUDI ARABIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 259. SOUTH AFRICA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 260. SOUTH AFRICA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 261. SOUTH AFRICA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 262. SOUTH AFRICA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 263. SOUTH AFRICA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 264. SOUTH AFRICA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 265. SPAIN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 266. SPAIN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 267. SPAIN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 268. SPAIN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 269. SPAIN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 270. SPAIN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 271. SWEDEN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 272. SWEDEN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 273. SWEDEN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 274. SWEDEN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 275. SWEDEN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 276. SWEDEN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 277. SWITZERLAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 278. SWITZERLAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 279. SWITZERLAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 280. SWITZERLAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 281. SWITZERLAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. SWITZERLAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. TURKEY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 284. TURKEY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 285. TURKEY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 286. TURKEY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 287. TURKEY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 288. TURKEY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 289. UNITED ARAB EMIRATES PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 290. UNITED ARAB EMIRATES PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 291. UNITED ARAB EMIRATES PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 292. UNITED ARAB EMIRATES PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 293. UNITED ARAB EMIRATES PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 294. UNITED ARAB EMIRATES PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 295. UNITED KINGDOM PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 296. UNITED KINGDOM PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 297. UNITED KINGDOM PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 298. UNITED KINGDOM PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 299. UNITED KINGDOM PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 300. UNITED KINGDOM PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 301. PRECLINICAL CRO MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 302. PRECLINICAL CRO MARKET, FPNV POSITIONING MATRIX, 2023